CDT vs CGEM

CDT Equity Inc. vs Cullinan Therapeutics, Inc. — Valuation Comparison 2026

CDT

Biotechnology
CDT Equity Inc.
Quality
4.1
out of 10
Value Trap
27
LOW
Price
$0.95
Last close
Models
8/13
Active
VS

CGEM

Biotechnology
Cullinan Therapeutics, Inc.
Quality
4.4
out of 10
Value Trap
24
SAFE
Price
$15.36
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType CDT Fair ValueCDT Upside CGEM Fair ValueCGEM Upside
Bayesian DCF Intrinsic $0.55 -41.9% $4.78 -68.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $1.71 -88.9%
Dynamic NAV Asset-Based $1.08 +13.8% $6.17 -59.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CDT vs CGEM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CDT vs CGEM — Which Stock Is More Undervalued?

CGEM scores higher with a 4.4/10 quality rating vs CDT's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing CDT Equity Inc. (CDT) and Cullinan Therapeutics, Inc. (CGEM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CDT currently trades at $0.95 with a QOC of 4.1/10, while CGEM trades at $15.36 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).